180 related articles for article (PubMed ID: 21826251)
1. Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells.
Tan L; Sui X; Deng H; Ding M
PLoS One; 2011; 6(8):e23383. PubMed ID: 21826251
[TBL] [Abstract][Full Text] [Related]
2. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
[TBL] [Abstract][Full Text] [Related]
3. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
6. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.
Zhang K; Waxman DJ
Mol Cancer; 2010 Dec; 9():319. PubMed ID: 21190562
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
Li SH; Fu J; Watkins DN; Srivastava RK; Shankar S
Mol Cell Biochem; 2013 Jan; 373(1-2):217-27. PubMed ID: 23129257
[TBL] [Abstract][Full Text] [Related]
8. BMI1 sustains human glioblastoma multiforme stem cell renewal.
Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
[TBL] [Abstract][Full Text] [Related]
9. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
[TBL] [Abstract][Full Text] [Related]
10. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
Wang H; Rana S; Giese N; Büchler MW; Zöller M
Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
[TBL] [Abstract][Full Text] [Related]
11. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.
Luo G; Long J; Cui X; Xiao Z; Liu Z; Shi S; Liu L; Liu C; Xu J; Li M; Yu X
Int J Oncol; 2013 Mar; 42(3):979-84. PubMed ID: 23338123
[TBL] [Abstract][Full Text] [Related]
12. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
Steg AD; Bevis KS; Katre AA; Ziebarth A; Dobbin ZC; Alvarez RD; Zhang K; Conner M; Landen CN
Clin Cancer Res; 2012 Feb; 18(3):869-81. PubMed ID: 22142828
[TBL] [Abstract][Full Text] [Related]
13. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
[TBL] [Abstract][Full Text] [Related]
14. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs.
Ning X; Du Y; Ben Q; Huang L; He X; Gong Y; Gao J; Wu H; Man X; Jin J; Xu M; Li Z
Cell Cycle; 2016; 15(3):403-12. PubMed ID: 26709750
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
18. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
Ji Q; Hao X; Zhang M; Tang W; Yang M; Li L; Xiang D; Desano JT; Bommer GT; Fan D; Fearon ER; Lawrence TS; Xu L
PLoS One; 2009 Aug; 4(8):e6816. PubMed ID: 19714243
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells.
Pinho AV; Rooman I; Real FX
Cell Cycle; 2011 Apr; 10(8):1312-21. PubMed ID: 21490434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
